Clinical trial
Evaluation of the Safety and Feasibility of a New Peripheral Oedema Monitor for Home and Clinical Use for Heart Failure Patients, Using the Heartfelt-1 Device
NCT02993601 is registered in ClinicalTrials.gov with Heartfelt Technologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Safety and Feasibility of a New Peripheral Oedema Monitor for Home and Clinical Use for Heart Failure Patients, Using the Heartfelt-1 Device
- Lead sponsor
- Heartfelt Technologies
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 15, 2017
- Completion date
- June 13, 2017
- Enrollment
- 70 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
decompensated heartfailure, edema brain, heart failure, diastolic